LIST OF TABLES
TABLE 1 AGEING WORLD POPULATION
TABLE 2 POSTOPERATIVE PULMONARY EMBOLISM OR DEEP VEIN THROMBOSIS IN HIP AND KNEE SURGERIES, 2015
TABLE 3 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 4 NORTH AMERICA DEEP VEIN THROMBOSIS (DVT) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 5 NORTH AMERICA PULMONARY EMBOLISM (PE) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 6 NORTH AMERICA ARTERIAL THROMBOEMBOLISM (AT) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 7 NORTH AMERICA STROKE IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 8 NORTH AMERICA OTHERS IN NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 9 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 10 NORTH AMERICA NOVEL ORAL ANTICOAGUALTANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 NORTH AMERICA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 12 NORTH AMERICA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 NORTH AMERICA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 14 NORTH AMERICA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 NORTH AMERICA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 16 NORTH AMERICA OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 18 NORTH AMERICA BIVALIRUDIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 NORTH AMERICA DABIGATRAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 20 NORTH AMERICA EDOXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 NORTH AMERICA BETRIXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 22 NORTH AMERICA RIVAROXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 NORTH AMERICA APIXABAN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 24 NORTH AMERICA ENOXAPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 25 NORTH AMERICA DALTEPARIN IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 26 NORTH AMERICA OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 27 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION , 2017-2026 (USD MILLION)
TABLE 28 NORTH AMERICA ORAL IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 29 NORTH AMERICA INJECTABLES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 30 NORTH AMERICA INJECTABLES IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 31 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 32 NORTH AMERICA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 33 NORTH AMERICA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 34 NORTH AMERICA ONCOLOGY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 35 NORTH AMERICA RESPIRATORY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 36 NORTH AMERICA NEPHROLOGY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 37 NORTH AMERICA CNS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 38 NORTH AMERICA OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 39 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 40 NORTH AMERICA PRE-SURGICAL PROCEDURES IN NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 41 NORTH AMERICA POST-SURGICAL PROCEDURES IN NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 42 NORTH AMERICA KIDNEY DIALYSIS IN NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 43 NORTH AMERICA HEART VALVE REPLACEMENT IN NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 44 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 45 NORTH AMERICA GENERICS IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 46 NORTH AMERICA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 47 NORTH AMERICA BRANDED IN NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 48 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 49 NORTH AMERICA HOSPITALS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 50 NORTH AMERICA CLINICS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 51 NORTH AMERICA HOMECARE IN ANTICOAGULATION THERAPY MARKET,BY REGION, 2017-2026 (USD MILLION)
TABLE 52 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 53 NORTH AMERICA OTHERS IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 54 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 55 NORTH AMERICA HOSPITAL PHARMACY IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 56 RETAIL PHARMACIES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 57 NORTH AMERICA ONLINE PHARMACIES IN ANTICOAGULATION THERAPY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 58 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 59 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 60 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 61 NORTH AMERICA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 62 NORTH AMERICA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 63 NORTH AMERICA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 64 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 65 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 66 NORTH AMERICA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 67 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 68 NORTH AMERICA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 69 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 70 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 71 NORTH AMERICA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 72 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 73 NORTH AMERICA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 74 U.S. ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 75 U.S. ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 76 U.S. NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 77 U.S. HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 78 U.S. VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 79 U.S. ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 80 U.S. ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 81 U.S. INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 82 U.S.ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 83 U.S. CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 84 U.S. ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 85 U.S. ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 86 U.S. BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 87 U.S. ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 88 U.S. ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 89 CANADA ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 90 CANADA ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 91 CANADA NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 92 CANADA HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 93 CANADA VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 94 CANADA ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 95 CANADA ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 96 CANADA INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 97 CANADA ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 98 CANADA CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 99 CANADA ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 100 CANADA ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 101 CANADA BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 102 CANADA ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 103 CANADA ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 104 MEXICO ANTICOAGULATION THERAPY MARKET, BY TREATMENT, 2017-2026 (USD MILLION)
TABLE 105 MEXICO ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 106 MEXICO NOVEL ORAL ANTICOAGULANTS (NOAC) IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 107 MEXICO HEPARIN IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 108 MEXICO VITAMIN K ANTAGONISTS IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC CLASS, 2017-2026 (USD MILLION)
TABLE 109 MEXICO ANTICOAGULATION THERAPY MARKET, BY DRUG TYPE, 2017-2026 (USD MILLION)
TABLE 110 MEXICO ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 111 MEXICO INJECTABLE IN ANTICOAGULATION THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017-2026 (USD MILLION)
TABLE 112 MEXICO ANTICOAGULATION THERAPY MARKET, BY THERPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 113 MEXICO CARDIOVASCULAR DISEASES IN ANTICOAGULATION THERAPY MARKET, BY THERAPEUTIC AREA, 2017-2026 (USD MILLION)
TABLE 114 MEXICO ANTICOAGULATION THERAPY MARKET, BY PROCEDURE, 2017-2026 (USD MILLION)
TABLE 115 MEXICO ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 116 MEXICO BRANDED IN ANTICOAGULATION THERAPY MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 117 MEXICO ANTICOAGULATION THERAPY MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 118 MEXICO ANTICOAGULATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

LIST OF FIGURE

LIST OF FIGURES
FIGURE 1 NORTH AMERICA ANTICOAGULATION THERAPY MARKET
FIGURE 2 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: DATA VALIDATION MODEL
FIGURE 3 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: NORTH AMERICA VS REGIONAL ANALYSIS
FIGURE 5 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA ANTICOAGULATION THERAPY MARKET
FIGURE 10 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA ANTICOAGULATION THERAPY MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 11 RISING PREVALENCE OF VENOUS THROMBOEMBOLISM AND PULMONARY EMBOLISM AND GROWING NUMBER OF SURGERIES ARE EXPECTED TO DRIVE THE NORTH AMERICA ANTICOAGULATION THERAPY MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 12 DEEP VEIN THROMBOSIS(DVT) IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ANTICOAGULATION THERAPY MARKET IN 2019 & 2026
FIGURE 13 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY TREATMENT, 2018
FIGURE 14 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY THERAPEUTIC CLASS, 2018
FIGURE 15 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY DRUG TYPE, 2018
FIGURE 16 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY ROUTE OF ADMINISTRATION, 2018
FIGURE 17 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY THERAPEUTIC AREA, 2018
FIGURE 18 NORTH AMERICA ANTICOAGULATION THERAPY TREATMENT MARKET: BY PROCEDURE, 2018
FIGURE 19 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY TYPE, 2018
FIGURE 20 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY END USER, 2018
FIGURE 21 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY DISTRIBUTION CHANNEL, 2018
FIGURE 22 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: SNAPSHOT (2018)
FIGURE 23 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY COUNTRY (2018)
FIGURE 24 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY COUNTRY (2019 & 2026)
FIGURE 25 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY COUNTRY (2018 & 2026)
FIGURE 26 NORTH AMERICA ANTICOAGULATION THERAPY MARKET: BY TREATMENT (2019-2026)
FIGURE 27 NORTH AMERICA ANTICOAGULATION THERPAY MARKET: COMPANY SHARE 2018 (%)